CLINICAL_TRIALS
trial_result
· 2014-01-10
Clinical Trial Update: A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis [Phase 3]
Summary
A Phase 3 clinical trial evaluating denosumab for postmenopausal osteoporosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2014-01-10